Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 31, 2017 ) According to Publisher, the Global Smart Inhalers market is accounted for $5.8 million in 2015 and is expected to reach $198 million by 2022 growing at a CAGR of 65.5% from 2015 to 2022. Increasing respiratory disorders, rise in air pollution, improved adherence to the inhaler are some of the factors boosting the market growth. However, lesser availability of smart inhalers, high expenditure of asthma and COPD treatment, and resistance towards adoption of smart inhalers are hindering the market growth.
For more information @ http://www.reportsweb.com/smart-inhalers-global-market-outlook-2016-2022
North America is projected to be the leading revenue generating region, whereas Asia-Pacific is projected to grow at the highest rate, due to rise in demand for smart inhalers and increase in COPD and asthma instances. Some of the key players in global Smart Inhalers market are Propeller Health, Glenmark Pharmaceuticals, Qualcomm Life, Opko Health, Adherium Limited, GlaxoSmithKline plc, Novartis AG, AstraZeneca plc , Boehringer Ingelheim GmbH, 3M Drug Delivery Systems, Sensirion AG, Novartis AG, CoheroHealth, Crux Product Design Ltd, e-pill, LLC, Vectura Group plc, Teva Pharmaceutical Industries Ltd., OMRON Healthcare Europe B.V, Shenzhen Bi-Rich Medical Devices Co., Ltd, Inspiro Medical Ltd, TRI-MED, INC., PARI GmbH and Philips Respironics.
Products Covered: - Inhalers - Nebulizers - Smater Dry Powder Inhalers (DPIs) - Metered Dose Inhalers (MDIs) Disorders Covered: - Asthma - Chronic Obstructive Pulmonary Disease (COPD) End Users Covered: - Patients - Research & Development
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001565000/sample Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
10 Company Profiling 10.1 Propeller Health 10.2 Glenmark Pharmaceuticals 10.3 Qualcomm Life 10.4 Opko Health 10.5 Adherium Limited 10.6 GlaxoSmithKline plc 10.7 Novartis AG 10.8 AstraZeneca plc 10.9 Boehringer Ingelheim GmbH 10.10 3M Drug Delivery Systems 10.11 Sensirion AG 10.12 Novartis AG 10.13 CoheroHealth 10.14 Crux Product Design Ltd 10.15 e-pill, LLC 10.16 Vectura Group plc 10.17 Teva Pharmaceutical Industries Ltd. 10.18 OMRON Healthcare Europe B.V 10.19 Shenzhen Bi-Rich Medical Devices Co., Ltd 10.20 Inspiro Medical Ltd 10.21 TRI-MED, INC. 10.22 PARI GmbH 10.23 Philips Respironics
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001565000/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|